No association of use of Inhaled corticosteroids and pneumonia risk in children
According to a study published in Thorax, there is no association between inhaled corticosteroids (ICS) and hospitalization risk due to pneumonia in pediatric patients.
More data need to be collected on the potential association between inhaled corticosteroid (ICS) use and the pneumonia risk among adults. The present study assessed the possible association between ICS, its use and the risk of hospitalization for pneumonia among children with a history of asthma aged 2-17 years.
The present study was based on nationwide data from routine clinical practice in Sweden from January 2007 to November 2021. From 425 965 children with confirmed asthma, using records of dispensed drugs, episodes of new ICS use and no use were identified. They adjusted for potential confounders with propensity score overlap weighting, and the hospitalization risk with pneumonia as the primary diagnosis was estimated. They also performed Multiple subgroup and sensitivity analyses.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.